DORAMECTIN INTOXICATION IN A FOAL AND USE OF FLUMAZENIL AS ADJUNCTIVE THERAPY: A CASE REPORT
DOI:
https://doi.org/10.25110/arqvet.v29i2.2026-12987Keywords:
Equine, Macrocyclic lactones, Neurotoxicity.Abstract
Doramectin is a macrocyclic lactone widely used for the control of nematodes and ectoparasites in domestic animals. Although considered safe at recommended therapeutic doses, overdoses may result in severe neurotoxicity, particularly in young animals. This study describes a case of doramectin intoxication in a Quarter Horse foal treated with intensive supportive therapy and adjunctive administration of flumazenil. A two-month-old foal developed unconsciousness and persistent recumbency approximately 48 hours after intramuscular administration of 3.5% doramectin at an estimated dose of 1.31 mg/kg, corresponding to approximately seven times the dose described in experimental studies of off-label use in horses. On clinical examination, the foal presented with a comatose state and bilateral absence of palpebral, pupillary light, and menace reflexes, in addition to laboratory abnormalities compatible with systemic impairment secondary to prolonged recumbency and intoxication. Intensive supportive therapy was instituted, including fluid therapy, recumbency management, enteral nutrition, and ocular protection. Due to the persistence of severe neurological impairment, flumazenil was administered at a dose of 0.01 mg/kg intravenously every two hours for 12 hours. Following the treatment protocol, the foal showed progressive neurological improvement, regaining the ability to stand and suckle spontaneously. Although the specific contribution of flumazenil cannot be determined, this case suggests a potential adjunctive application of the drug in macrocyclic lactone intoxication and highlights the need for further studies in horses.
Downloads
References
BATIHA, G. E. S. et al. Avermectin derivatives, pharmacokinetics, therapeutic and toxic doses, mechanism of action and biological effects. Pharmaceuticals, v. 13, n. 8, p. 196, 2020. DOI: https://doi.org/10.3390/ph13080196.
BLOOMQUIST, J. R. Chloride channels as tools for developing selective insecticides. Archives of Insect Biochemistry and Physiology, v. 54, n. 4, p. 145–156, 2003. DOI: https://doi.org/10.1002/arch.10112.
BRÜNISHOLZ, H. et al. Treatment of ivermectin overdose in a miniature Shetland pony using intravenous administration of a lipid emulsion. Journal of Veterinary Internal Medicine, v. 26, n. 2, p. 407–411, 2012. DOI: https://doi.org/10.1111/j.1939-1676.2011.00865.x.
DA SILVA ROCHA, L. et al. Iatrogenic doramectin poisoning in newborn beef calves. Veterinary Research Communications, v. 50, n. 2, p. 137, 2026. DOI: https://doi.org/10.1007/s11259-026-11082-x.
DARBY, S.; DENOTTA, S.; GOMEZ, D. E. Ivermectin toxicosis in a foal: use of intravenous lipid emulsion therapy. Canadian Veterinary Journal, v. 66, n. 9, p. 1004–1008, 2025.
FEDERICI, L. et al. Perinatal maturation of drug transporters and claudin-5 at the blood-brain barrier. CNS Neuroscience & Therapeutics, v. 31, n. 9, e70614, 2025. DOI: https://doi.org/10.1111/cns.70614.
FURR, M.; REED, S. (eds.). Equine neurology. 2. ed. Hoboken: Wiley-Blackwell, 2015. DOI: https://doi.org/10.1002/9781118993712.
GEYER, J.; GAVRILOVA, O.; PETZINGER, E. Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp-deficient knockout mice. Journal of Veterinary Pharmacology and Therapeutics, v. 32, n. 1, p. 87–96, 2009. DOI: https://doi.org/10.1111/j.1365-2885.2008.01007.x.
GWALTNEY-BRANT, S. M.; DECLEMENTI, C.; GUPTA, R. C. Macrocyclic lactone endectocides. In: GUPTA, R. C. (ed.). Veterinary toxicology. 3. ed. Amsterdam: Elsevier, 2018. p. 539–550. DOI: https://doi.org/10.1016/B978-0-12-811410-0.00043-X.
HOOD, S. et al. Benzodiazepine dependence and its treatment with low dose flumazenil. British Journal of Clinical Pharmacology, v. 77, n. 2, p. 285–294, 2014. DOI: https://doi.org/10.1111/bcp.12023.
HOPPER, K.; ALDRICH, J.; HASKINS, S. C. Ivermectin toxicity in 17 collies. Journal of Veterinary Internal Medicine, v. 16, n. 1, p. 89–94, 2002. DOI: https://doi.org/10.1111/j.1939-1676.2002.tb01611.x.
KIKI-MVOUAKA, S. et al. Role of P-glycoprotein in the disposition of macrocyclic lactones: a comparison between ivermectin, eprinomectin, and moxidectin in mice. Drug Metabolism and Disposition, v. 38, n. 4, p. 573–580, 2010. DOI: https://doi.org/10.1124/dmd.109.030700.
MCKELLAR, Q. A.; BENCHAOUI, H. A. Avermectins and milbemycins. Journal of Veterinary Pharmacology and Therapeutics, v. 19, n. 5, p. 331–351, 1996. DOI: https://doi.org/10.1111/j.1365-2885.1996.tb00062.x.
MEYER, H. P.; LEGEMATE, D. A.; VAN DEN BROM, W. E.; ROTHUIZEN, J. Improvement of chronic hepatic encephalopathy in dogs by the partial inverse agonist of the benzodiazepine receptor sarmazenil, but not by the antagonist flumazenil. Metabolic Brain Disease, v. 13, n. 3, p. 241–251, 1998. DOI: https://doi.org/10.1023/A:1023228126315.
MÜLLER, J. M.; FEIGE, K.; KÄSTNER, S. B. R.; NAEGELI, H. The use of sarmazenil in the treatment of a moxidectin intoxication in a foal. Journal of Veterinary Internal Medicine, v. 19, n. 3, p. 348–349, 2005. DOI: https://doi.org/10.1111/j.1939-1676.2005.tb02706.x.
PAPICH, M. G. Saunders handbook of veterinary drugs: small and large animals. 4. ed. St. Louis: Elsevier/Saunders, 2016.
SALMAN, M. et al. Assessment of Avermectins-Induced Toxicity in Animals. Pharmaceuticals, v. 15, n. 3, p. 332, 2022. DOI: https://doi.org/10.3390/ph15030332.
SIEGHART, W. Structure, pharmacology, and function of GABA-A receptors. Advances in Pharmacology, v. 54, p. 231–263, 2006. DOI: https://doi.org/10.1016/S1054-3589(06)54010-4.
SIVILOTTI, M. L. A. Flumazenil, naloxone and the “coma cocktail”. British Journal of Clinical Pharmacology, v. 81, n. 3, p. 428–436, 2016. DOI: https://doi.org/10.1111/bcp.12731.
SUN, B.; JIA, L.; NIE, S. Administration of flumazenil in a patient with acute abamectin intoxication: case report and review of the literature. West Indian Medical Journal, v. 64, n. 2, p. 162–164, 2015. DOI: https://doi.org/10.7727/wimj.2013.306.
SWOR, T. M.; WHITTENBURG, J. L.; CHAFFIN, M. K. Ivermectin toxicity in three adult horses. Journal of the American Veterinary Medical Association, v. 235, n. 5, p. 558–562, 2009. DOI: https://doi.org/10.2460/javma.235.5.558.
VERSCHEIJDEN, L. F. M. et al. Differences in P-glycoprotein activity in human and rodent blood-brain barrier assessed by mechanistic modelling. Archives of Toxicology, v. 95, n. 9, p. 3015–3029, 2021. DOI: https://doi.org/10.1007/s00204-021-03115-y.
YANG, C.-C. Acute human toxicity of macrocyclic lactones. Current Pharmaceutical Biotechnology, v. 13, n. 6, p. 999–1003, 2012. DOI: https://doi.org/10.2174/138920112800399059.
YILMAZ, S.; GÖKTAŞ, B.; ATEŞ, İ.; ÇELİK, M. Ivermectin toxicity in humans and animals: clinical spectrum, mechanisms, and management. Journal of Applied Toxicology, v. 46, n. 6, p. 1856–1870, 2026. DOI: https://doi.org/10.1002/jat.70166.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Camila Angela Marques, Jéssica Diniz Stein, Michely de Almeida Pittelkow, Álvaro de Paula Lage de Oliveira, Thaís Gomes Rocha, Otavio Luiz Fidelis Junior

This work is licensed under a Creative Commons Attribution 4.0 International License.





